GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Short Interest

Kane Biotech (TSXV:KNE) Short Interest


View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Kane Biotech's Short Interest

For the Biotechnology subindustry, Kane Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Kane Biotech's Short Interest falls into.


;
;

Kane Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Short Interest
Comparable Companies
XCNQ:TELI TSX:CSCI XCNQ:PREV XCNQ:MDMA TSXV:HEM XCNQ:BETR TSXV:SBM XCNQ:BIOV TSX:RVX TSXV:CYTO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
KNBIF:USA
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Website
https://www.kanebiotech.com
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.
Executives
Marc Edwards Director
Philip Renaud Director
Raymond David Eugene Dupuis Senior Officer
Richard J. Renaud 10% Security Holder
Georges Morin Director
Rashieda Gluck Director

Kane Biotech Headlines

No Headlines